Development and Evaluation of NK-CD123 CAR Against High Risk Acute Myeloid Leukemia

Biology of Blood and Marrow Transplantation - Netherlands
doi 10.1016/j.bbmt.2016.12.423
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Distribution and Levels of Cell Surface Expression of CD33 and CD123 in Acute Myeloid Leukemia

Blood Cancer Journal
OncologyHematology
2014English

CD30 Expression in High-Risk Acute Myeloid Leukemia and Myelodysplastic Syndromes

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2013English

Acute Myeloid Leukemia and NK Cells: Two Warriors Confront Each Other

OncoImmunology
OncologyAllergyImmunology
2018English

CD123 Targeting Oncolytic Adenoviruses Suppress Acute Myeloid Leukemia Cell Proliferation in Vitro and in Vivo

Blood Cancer Journal
OncologyHematology
2014English

Characterization of Leukemia-Specific NK Cell Subsets Against Acute Lymphoblastic Leukemia in Children

Molecular and Cellular Pediatrics
Child HealthPediatricsPerinatologyMolecular BiologyCell Biology
2014English

Acute Myeloid Leukemia

JAMA - Journal of the American Medical Association
Medicine
2010English

Acute Myeloid Leukemia

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2012English

In Vitro Evaluation of Triazenes: DNA Cleavage, Antibacterial Activity and Cytotoxicity Against Acute Myeloid Leukemia Cells

Journal of the Brazilian Chemical Society
Chemistry
2010English

Sequential Allogeneic Stem Cell Transplantation in High Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome

Biology of Blood and Marrow Transplantation
TransplantationHematology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy